Board of trustees

Members

Dr. Karin Conde-Knape

Corporate Vice President Diabetes, Cardio-Renal and Translational Research, Novo Nordisk A/S (Denmark)

Prof. Dr. Wolfgang Herr

Full professor and Head of the Department of Internal Medicine III, University Hospital Regensburg

Prof. Dr. Edith M. Hessel

Chief Scientific Officer, Eligo Bioscience (UK)

Prof. Dr. Michael Hildebrand

Managing Director, Hildebrand Pharma Consulting

Dr. Sylvia Jacobi

Corporate Toxicology Director, Albemarle Europe (Belgium)

Prof. Dr. Dieter Jahn

Head of the Institute of Microbiology, Technische Universität Braunschweig,
Spokesman of the Braunschweig Integrated Centre of Systems Biology – BRICS

Dr. Frank Kalkbrenner

Managing Director, Boehringer Ingelheim Corporate Venture Fund

Prof. Prof. h. c. Dr. Thomas Lenarz

Director of the Department of Otorhinolaryngology
and Director of Deutsches HörZentrum, Hannover Medical School

Prof. Dr. Michael P. Manns

President and Member of the Presidium responsible for the Division of Research and Teaching, Hannover Medical School

Ministerialrätin Dr. Evelyn Obele

Head of the Division of Health Research, Medical Technology, German Federal Ministry of Education and Research

Prof. Clive Page, OBE, Ph.D.

Head of Sackler Institute of Pulmonary Pharmacology,
School of Cancer and Pharmaceutical Science,
King’s College London (UK)

Prof. Dr. Werner Seeger

Director of the Department of Pulmonology, Internal Intensive Care, Infectiology, Gastroenterology, Nephrology, University Hospital Giessen UKGM

Anna Teschner

Head of the Division of Life Sciences, Humanities, Social Sciences and Academic Libraries, Lower Saxony Ministry of Science and Culture

Dr. Torsten Wagner

Senior Vice President, Corporate Technical Operations,
Merz Pharma GmbH & Co. KGaA

At present, the Fraunhofer ITEM board of trustees is made up of the following members:

Chairman of the board of trustees

Prof. Dr. Paul-Georg Germann